H01422 | |
H number | H01422 |
Name | Carbapenem-resistant bacterial infection |
Description | Carbapenems [DG:DG01458] are a class of beta-lactam antibiotics often used as the last resort treatment for severe bacterial infections. Thus, the appearance of carbapenem resistance caused by acquisition of carbapenem-hydrolyzing beta-lactamases (carbapenemases), especially among Enterobacteriaceae, Pseudomonas and Acinetobacter, is considered as a global health threat. |
Category | Bacterial infectious disease |
Network | - |
Gene | - |
Pathogen | Enterobacteriaceae Pseudomonas Acinetobacter |
Env factor | - |
Carcinogen | - |
Drug | - |
Comment | - |
Other DBs | ICD-11: MG50.02 MG50.24 MG50.92 MG50.A0 MG50.C0 ICD-10: U82.8 |
Reference | PMID:24360201 AUTHORS Nordmann P TITLE Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. JOURNAL Med Mal Infect 44:51-6 (2014) DOI:10.1016/j.medmal.2013.11.007 PMID:21859938 AUTHORS Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA TITLE Carbapenems: past, present, and future. JOURNAL Antimicrob Agents Chemother 55:4943-60 (2011) DOI:10.1128/AAC.00296-11 |